Profound Medical Corp. Announces Real-Time Interventional MRI Software

What Happened Profound Medical Corp. (PROF) filed a Form 8-K on August 17, 2026 (Item 7.01) to disclose, under Regulation FD, the launch of its new real-time interventional MRI software. The company furnished a press release dated August 17, 2026 as Exhibit 99.1 to the 8-K. The report was signed by Arun Menawat, Chief Executive Officer and Chairman.

Key Details

• Filing date: August 17, 2026 (Form 8-K, Item 7.01 – Regulation FD Disclosure).
• Announcement: Introduction of Profound’s new real-time interventional MRI software (press release furnished as Exhibit 99.1).
• Signature: Form 8-K signed by Arun Menawat, CEO and Chairman.
• Administrative exhibit filed: Exhibit 99.1 (press release); Inline XBRL cover page included under Item 9.01.

Why It Matters This 8-K is a company disclosure announcing a new product offering—real-time interventional MRI software—which is a strategic business update rather than a financial filing. For investors, the filing signals a product development milestone; monitor future filings and company communications for details on commercialization, clinical results, partnerships, sales, or any impact on revenue and guidance.